创新-话题@MedSci

#创新#

1015篇内容 | 8178人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1285873, encodeId=a38a12858e3d6, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=2020医药创新指数排行榜，恒瑞成为中国**上榜企业，全球第13, objectType=article, longId=196219, objectId=0fe3196219d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0fe3196219d1, replyNumber=0, likeNumber=66, createdTime=2020-06-22, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0fe3196219d1, moduleTitle=2020医药创新指数排行榜，恒瑞成为中国**上榜企业，全球第13, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0fe3196219d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285872, encodeId=3d4712858e24a, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=祝贺！“35岁以下科技创新人”榜单新鲜出炉，11位生物医药新星入选, objectType=article, longId=196176, objectId=e5da1961e67a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e5da1961e67a, replyNumber=0, likeNumber=78, createdTime=2020-06-22, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e5da1961e67a, moduleTitle=祝贺！“35岁以下科技创新人”榜单新鲜出炉，11位生物医药新星入选, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e5da1961e67a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285871, encodeId=545712858e10e, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=创新倒逼改革！中国医疗格局新变革来了, objectType=article, longId=196129, objectId=604b1961295f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=604b1961295f, replyNumber=0, likeNumber=78, createdTime=2020-06-21, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=604b1961295f, moduleTitle=创新倒逼改革！中国医疗格局新变革来了, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=604b1961295f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285870, encodeId=505512858e0c3, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=助力“国人大病不出国” 博鳌乐城加速进口创新药, objectType=article, longId=196055, objectId=6aef19605560, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6aef19605560, replyNumber=0, likeNumber=58, createdTime=2020-06-19, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6aef19605560, moduleTitle=助力“国人大病不出国” 博鳌乐城加速进口创新药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6aef19605560)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285869, encodeId=d9ca128586986, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=6月14日全球新冠肺炎（COVID-19）疫情简报，新增屡创新高，巴西超85万, objectType=article, longId=195872, objectId=a1761958e202, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1761958e202, replyNumber=0, likeNumber=54, createdTime=2020-06-15, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1761958e202, moduleTitle=6月14日全球新冠肺炎（COVID-19）疫情简报，新增屡创新高，巴西超85万, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a1761958e202)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285868, encodeId=92e412858685a, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=6月12日全球新冠肺炎（COVID-19）疫情简报，确诊超758万例，新增创新高, objectType=article, longId=195760, objectId=e42b195e60ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e42b195e60ff, replyNumber=0, likeNumber=57, createdTime=2020-06-13, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e42b195e60ff, moduleTitle=6月12日全球新冠肺炎（COVID-19）疫情简报，确诊超758万例，新增创新高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e42b195e60ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285867, encodeId=bc21128586eba, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=光明中医科普工程二期启动推动中医药传承创新发展, objectType=article, longId=195653, objectId=4e5919565329, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e5919565329, replyNumber=0, likeNumber=75, createdTime=2020-06-12, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e5919565329, moduleTitle=光明中医科普工程二期启动推动中医药传承创新发展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e5919565329)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285866, encodeId=a46312858667f, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=6月6日全球新冠肺炎（COVID-19）疫情简报，超683万例，单日新增创新高, objectType=article, longId=195417, objectId=f32319541ef9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f32319541ef9, replyNumber=0, likeNumber=66, createdTime=2020-06-07, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f32319541ef9, moduleTitle=6月6日全球新冠肺炎（COVID-19）疫情简报，超683万例，单日新增创新高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f32319541ef9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285865, encodeId=d072128586518, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=2020医学界有哪些医疗创新？, objectType=article, longId=195365, objectId=ee9f19536596, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee9f19536596, replyNumber=0, likeNumber=59, createdTime=2020-06-07, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee9f19536596, moduleTitle=2020医学界有哪些医疗创新？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee9f19536596)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285863, encodeId=38d2128586385, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=委员霍勇：发挥医生在创新中的主体作用建立完善的医学创新生态链, objectType=article, longId=195210, objectId=78eb1952106b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=78eb1952106b, replyNumber=0, likeNumber=66, createdTime=2020-06-04, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=78eb1952106b, moduleTitle=委员霍勇：发挥医生在创新中的主体作用建立完善的医学创新生态链, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=78eb1952106b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285862, encodeId=3da412858624f, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=6月2日全球新冠肺炎（COVID-19）简报，确诊超636万，日康复超10.9万人，创新高, objectType=article, longId=195145, objectId=9c91195145ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9c91195145ca, replyNumber=0, likeNumber=55, createdTime=2020-06-03, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9c91195145ca, moduleTitle=6月2日全球新冠肺炎（COVID-19）简报，确诊超636万，日康复超10.9万人，创新高, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9c91195145ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285861, encodeId=c8281285861f8, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=5月31日全球新冠肺炎（COVID-19）疫情简报，确诊超615万，日新增创新高，美国终止与WHO关系, objectType=article, longId=195034, objectId=976b1950347a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=976b1950347a, replyNumber=0, likeNumber=67, createdTime=2020-06-01, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=976b1950347a, moduleTitle=5月31日全球新冠肺炎（COVID-19）疫情简报，确诊超615万，日新增创新高，美国终止与WHO关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=976b1950347a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285860, encodeId=7f5d12858608d, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=天境生物宣布其靶向白介素rhIL-7的创新药物获中国临床2期试验许可！, objectType=article, longId=194627, objectId=6aa819462eed, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6aa819462eed, replyNumber=0, likeNumber=78, createdTime=2020-05-25, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6aa819462eed, moduleTitle=天境生物宣布其靶向白介素rhIL-7的创新药物获中国临床2期试验许可！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6aa819462eed)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285864, encodeId=2d00128586471, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=赛诺菲持续加码胰岛素生产布局，推动药品和疾病解决方案的创新, objectType=article, longId=194589, objectId=7b8419458981, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b8419458981, replyNumber=0, likeNumber=68, createdTime=2020-05-24, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b8419458981, moduleTitle=赛诺菲持续加码胰岛素生产布局，推动药品和疾病解决方案的创新, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b8419458981)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285859, encodeId=83da1285859e8, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=重庆两江新区将建健康医疗大数据及人工智能应用创新平台, objectType=article, longId=194354, objectId=c0a8194354af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c0a8194354af, replyNumber=0, likeNumber=79, createdTime=2020-05-20, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c0a8194354af, moduleTitle=重庆两江新区将建健康医疗大数据及人工智能应用创新平台, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c0a8194354af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285858, encodeId=da2812858586e, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=直播预告|“中西合璧聚力前行”肿瘤综合治疗创新之路高峰论坛邀您参加！, objectType=article, longId=194353, objectId=e52419435347, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e52419435347, replyNumber=0, likeNumber=53, createdTime=2020-05-20, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e52419435347, moduleTitle=直播预告|“中西合璧聚力前行”肿瘤综合治疗创新之路高峰论坛邀您参加！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e52419435347)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285857, encodeId=50e4128585e58, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=淋巴瘤患者治疗新选择：武田靶向CD30的创新抗体偶联药物（注射用维布妥昔单抗）正式获批 , objectType=article, longId=194204, objectId=9ef5194204f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9ef5194204f6, replyNumber=0, likeNumber=61, createdTime=2020-05-17, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9ef5194204f6, moduleTitle=淋巴瘤患者治疗新选择：武田靶向CD30的创新抗体偶联药物（注射用维布妥昔单抗）正式获批 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9ef5194204f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285856, encodeId=51c612858569c, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=王树森教授：西达本胺为HR+/HER2-乳腺癌带来治疗革新，中国原创新药助力乳腺癌长期生存, objectType=article, longId=194099, objectId=ae38194099b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae38194099b1, replyNumber=0, likeNumber=80, createdTime=2020-05-15, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae38194099b1, moduleTitle=王树森教授：西达本胺为HR+/HER2-乳腺癌带来治疗革新，中国原创新药助力乳腺癌长期生存, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae38194099b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285855, encodeId=d30d12858552a, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=国家药监局优先审评审批，新一代国产肺癌创新药上市, objectType=article, longId=193935, objectId=19e91939353f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=19e91939353f, replyNumber=0, likeNumber=74, createdTime=2020-05-12, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=19e91939353f, moduleTitle=国家药监局优先审评审批，新一代国产肺癌创新药上市, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=19e91939353f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1285854, encodeId=d84912858545d, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, objectTitle=5月5日全球新冠肺炎（COVID-19）疫情简报，确诊364万，日死亡人数创新低，面临严防疫情还是重启经济两难选择, objectType=article, longId=193527, objectId=566719352edf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=566719352edf, replyNumber=0, likeNumber=72, createdTime=2020-05-06, rootId=0, userName=lilianxiang, userId=512a199, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=566719352edf, moduleTitle=5月5日全球新冠肺炎（COVID-19）疫情简报，确诊364万，日死亡人数创新低，面临严防疫情还是重启经济两难选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=566719352edf)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

创新

2020-05-29

lilianxiang (审核中...)

前往app查看评论内容

#创新#

2020医药创新指数排行榜，恒瑞成为中国**上榜企业，全球第13

2020-06-22

lilianxiang (审核中...)

前往app查看评论内容

#创新#

祝贺！“35岁以下科技创新人”榜单新鲜出炉，11位生物医药新星入选

2020-06-22

lilianxiang (审核中...)

前往app查看评论内容

#创新#

创新倒逼改革！中国医疗格局新变革来了

2020-06-21

lilianxiang (审核中...)

前往app查看评论内容

#创新#

助力“国人大病不出国” 博鳌乐城加速进口创新药

2020-06-19

lilianxiang (审核中...)

前往app查看评论内容

#创新#

6月14日全球新冠肺炎（COVID-19）疫情简报，新增屡创新高，巴西超85万

2020-06-15

lilianxiang (审核中...)

前往app查看评论内容

#创新#

6月12日全球新冠肺炎（COVID-19）疫情简报，确诊超758万例，新增创新高

2020-06-13

lilianxiang (审核中...)

前往app查看评论内容

#创新#

光明中医科普工程二期启动推动中医药传承创新发展

2020-06-12

lilianxiang (审核中...)

前往app查看评论内容

#创新#

6月6日全球新冠肺炎（COVID-19）疫情简报，超683万例，单日新增创新高

2020-06-07

lilianxiang (审核中...)

前往app查看评论内容

#创新#

2020医学界有哪些医疗创新？

2020-06-07

lilianxiang (审核中...)

前往app查看评论内容

#创新#

委员霍勇：发挥医生在创新中的主体作用建立完善的医学创新生态链

2020-06-04

lilianxiang (审核中...)

前往app查看评论内容

#创新#

6月2日全球新冠肺炎（COVID-19）简报，确诊超636万，日康复超10.9万人，创新高

2020-06-03

lilianxiang (审核中...)

前往app查看评论内容

#创新#

5月31日全球新冠肺炎（COVID-19）疫情简报，确诊超615万，日新增创新高，美国终止与WHO关系

2020-06-01

lilianxiang (审核中...)

前往app查看评论内容

#创新#

天境生物宣布其靶向白介素rhIL-7的创新药物获中国临床2期试验许可！

2020-05-25

lilianxiang (审核中...)

前往app查看评论内容

#创新#

赛诺菲持续加码胰岛素生产布局，推动药品和疾病解决方案的创新

2020-05-24

lilianxiang (审核中...)

前往app查看评论内容

#创新#

重庆两江新区将建健康医疗大数据及人工智能应用创新平台

2020-05-20

lilianxiang (审核中...)

前往app查看评论内容

#创新#

直播预告|“中西合璧聚力前行”肿瘤综合治疗创新之路高峰论坛邀您参加！

2020-05-20

lilianxiang (审核中...)

前往app查看评论内容

#创新#

淋巴瘤患者治疗新选择：武田靶向CD30的创新抗体偶联药物（注射用维布妥昔单抗）正式获批

2020-05-17

lilianxiang (审核中...)

前往app查看评论内容

#创新#

王树森教授：西达本胺为HR+/HER2-乳腺癌带来治疗革新，中国原创新药助力乳腺癌长期生存

2020-05-15

lilianxiang (审核中...)

前往app查看评论内容

#创新#

国家药监局优先审评审批，新一代国产肺癌创新药上市

2020-05-12

lilianxiang (审核中...)

前往app查看评论内容

#创新#

5月5日全球新冠肺炎（COVID-19）疫情简报，确诊364万，日死亡人数创新低，面临严防疫情还是重启经济两难选择

2020-05-06

科室
- - 订阅+
  - 更多科室
工具
服务